R ed blood cell distribution width (RDW) is an expression of the variation in size of the red blood cells that make up the total population in an individual patient. RDW is calculated as the SD in red blood cell (RBC) size divided by the mean corpuscular volume. The individual RBC sizes are determined in an automated fashion by flow cytometry. RDW is widely available, inexpensive, and included in the complete blood count panel. The normal range of RDW is 11.5% to 14.5% with no clinical scenarios that produce RDW Ͻ11.5%. Any process that results in the release of reticulocytes into the circulation will result in an increase in RDW.
admission is associated with increased risk of 1-yr mortality (4) . Furthermore, higher baseline RDW independently predicts subsequent risk of both cardiovascular death and all-cause mortality in those with acute stroke (5) . Although the mechanism of a RDW-mortality association is unclear, the association may be related to inflammation and the contribution of inflammation to the pathophysiology of disease (2, 6 -8) .
In general, RDW is reflective of inflammation (2) . In the general population and in those with heart failure, higher RDW is associated with increases in erythrocyte sedimentation rate and the inflammatory markers interleukin-6, Creactive protein, and receptors for tumor necrosis factor I and II (9 -12) . Proinflammatory cytokines found in patients with systemic inflammatory response syndrome including tumor necrosis factor-␣, interleukin-6, and interleukin-1␤ are noted to suppress erythrocyte maturation, allowing newer, larger reticulocytes to enter the peripheral circulation and increase RDW (13, 14) . Furthermore, proinflammatory cytokines can have direct inhibitory effects on the half-life of red blood cell circulation and deformability of the red blood cell membrane, which in turn can manifest as an increase in RDW (13, 15, 16) . These observations provide support for the biological plausibility of RDW as a marker of inflammation in critical illness.
Despite these observations, the prevalence of increased RDW and its significance in critical care are not well studied. In a study of 47 surgical intensive care unit (ICU) patients from 1994, South African investigators reported 82% of cohort patients had wider RDW than control subjects (17) . In a recent prospective single-center study from China, investigators noted a 1.6-fold increase in hospital mortality (albeit inadequately adjusted) with increased RDW in 602 critically ill medical patients (18) . Taken together, increased RDW is present in the critically ill and may be associated with adverse outcomes.
Thus, we hypothesized that inflammation in the critically ill, reflected by a higher RDW, may increase the risk for bloodstream infections and be related to patient survival. To explore the role of increased RDW in the outcome of the critically ill, we performed a multicenter observational study of 51,785 critically ill patients hospitalized between 1997 and 2007. The objectives of this study were : 1) to determine the relationship between RDW at critical care initiation and allcause mortality; and 2) to determine the association between RDW critical care initiation and bloodstream infection.
MATERIALS AND METHODS
Source Population. We extracted administrative and laboratory data from individuals admitted to two academic teaching hospitals in Boston, MA. Brigham and Women's Hospital is a 777-bed teaching hospital with 100 ICU beds. Massachusetts General Hospital is a 902bed teaching hospital with 109 ICU beds. The two hospitals provide primary as well as tertiary care to an ethnically and socioeconomically diverse population within eastern Massachusetts and the surrounding region.
Data Sources. Data on all patients admitted to Brigham and Women's Hospital or Massachusetts General Hospital between November 2, 1997, and December 31, 2007, were obtained through a computerized registry, which serves as a central clinical data warehouse for all inpatients and outpatients seen at these hospitals. The database contains information on demographics, medications, laboratory values, microbiology data, procedures, and the records of inpatient and outpatients. Approval for the study was granted by the institutional review board of Brigham and Women's Hospital.
The following data were retrieved: demographics, vital status for up to 10 yrs following critical care initiation, hospital admission and discharge date, laboratory values, blood bank reports, microbiology reports, diagnosisrelated group assigned at discharge, International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes, and current procedural terminology (CPT) codes for inhospital procedures and services.
During the 10-yr study period, there were 54,392 unique patients, aged Ն18 yrs, who were assigned the CPT code 99,291 (critical care, first 30 -74 mins). Two hundred five foreign patients without Social Security Numbers were identified and excluded because vital status in this study is determined by the Social Security Death Index. We also excluded 2372 patients assigned CPT code 99,291 who received care only in the emergency room, were not admitted, and were not assigned a diagnosis-related group. Because a high white blood cell count may skew the automatically calculated RDW (19) , 29 patients were excluded who had white blood cells Ͼ150,000/L. One hundred sixty-six patients were excluded for missing data. A total of 51,413 patients constituted the study cohort.
Exposure of Interest and Comorbidities. The exposure of interest was RDW at critical care initiation and categorized a priori as Յ13.3%, 13.3% to 14.0%, 14.0% to 14.7%, 14.7% to 15.8%, and Ͼ15.8% (3).
Sepsis was defined by the presence of any of the following ICD-9-CM codes: 038.0 -038.9, 020.0, 790.7, 117.9, 112.5, and 112.81 3 days before critical care initiation to 7 days after critical care initiation (20) . Acute myocardial infarct is defined by ICD-9-CM 410.0 -410.9 (21) before or on the day of critical care initiation. Congestive heart failure is defined by ICD-9-CM 428.0 -428.4 before or on the day of critical care initiation (22) . Number of organs with failure was adapted from a study by Martin et al (20) and defined by a combination of ICD-9-CM and CPT codes relating to acute organ dysfunction assigned from 3 days before critical care initiation to 30 days after critical care initiation as outlined in the Supplemental Digital Content.
Transfusion data were obtained by blood bank reports. Red blood cell transfusion unit amount, date, and time were recorded. Only patients who received red blood cell transfusions in the 48 hrs before critical care initiation and during the ICU stay were considered to have received transfusions.
Patient type is defined as medical or surgical and incorporates the diagnosis-related group methodology devised by Centers for Medicare & Medicaid Services (23) . Procedures were determined by CPT codes as follows: coronary artery bypass grafting (CABG) surgery performed on the day before or day after critical care initiation (CPT codes 33,510 -33,536).
The Deyo-Charlson index was used to assess the burden of chronic illness (24) . The Deyo-Charlson index consists of 17 comorbidities, which are weighted and summed to produce a score each with an associated weight based on the risk of 1-yr mortality. This score ranges from 0 to 33 with higher scores indicating a higher burden. The score does not measure type or severity of acute illness (24, 25) . We used the ICD-9 coding algorithms developed in the study by Quan et al (26) to derive a Deyo-Charlson index for each patient. The validity of the algorithms for ICD-9 coding from administrative data are reported (26) . As a result of the relatively low representation, Deyo-Charlson index scores Ն5 were combined.
All patients who had blood cultures drawn 48 hrs before 48 hrs subsequent to critical care initiation were identified. Blood cultures were defined as positive if aerobic, anaerobic, or fungal blood cultures grew identifiable organisms. Patients with positive blood cultures were considered to have bloodstream infections (27) (28) (29) .
Assessment of Mortality. Information on vital status for the study cohort was obtained from the Social Security Administration Death Master File. Data from the Social Security Administration Death Master File has a reported sensitivity for mortality up to 92.1% with a specificity of 99.9% in comparison to Ͼ95% with National Death Index as the gold standard (30 -33) . The administrative database from which our study cohort is derived is updated monthly using Social Security Administration Death Master File, which itself is updated weekly (32, 34) . Use of the Death Master File allows for long-term follow-up of patients after hospital discharge. The censoring date was July 27, 2009 .
End Points. The primary end point was 30-day mortality after critical care initiation. Other prespecified end points included 90-day, 365-day, inhospital mortality, and bloodstream infection.
Statistical Analysis. Categorical covariates were described by frequency distribution and compared across RDW groups using contingency tables and chi-square testing. Continuous covariates were examined graphically (e.g., histogram, box plot) and in terms of summary statistics (mean, SD, median, interquartile range) and compared across exposure groups using one-way analysis of variance. Survival analyses considered death by days 30, 90, and 365 postcritical care initiation as well as inhospital mortality. In each instance, subjects were excluded if they were censored for incomplete data. Three hundred sixty-five-day follow-up was present for all 51,413 patients in the cohort.
Unadjusted associations between RDW groups and outcomes were estimated by contingency tables, chi-square testing, and by bivariable logistic regression analysis. Adjusted odds ratios were estimated by multivariable logistic regression models with inclusion of covariate terms thought to plausibly interact with both RDW and mortality or both RDW and bloodstream infection. Covariate terms included in the model included age, sex, race, Deyo-Charlson index, patient type (surgical vs. medical), CABG, myocardial infarction, congestive heart failure, hematocrit, transfusion, white blood count, mean corpuscular volume, blood urea nitrogen, sepsis, and creatinine. For the primary model (30-day mortality), specification of each continuous covariate (as a linear vs. categorical term) was adjudicated by the empiric association with the primary outcome using Akaike's information criterion; overall model fit was assessed using the Hosmer-Lemeshow test. The number of organs with failure variable was not adjusted for because it shares ICD-9 codes with the Deyo-Charlson index.
Models for secondary analyses (90-day, 365-day, and inhospital mortality and bloodstream infection) were specified identically to the primary model to bear greatest analogy. We assessed possible effect modification of transfusion, anemia, or sepsis on the risk of mortality and transfusion on the risk of bloodstream infection. We tested the significance of the interaction using the likelihood ratio test. The discrimination of RDW for mortality was evaluated using receiver operating characteristic curves. The area under the receiver operating characteristic curve (AUC) is an expression of the ability of RDW as a continuous variable to distinguish vital status at 30 days after critical care initiation (35) . All p values presented are two-tailed; values Ͻ.05 were considered nominally significant. All analyses are performed using STATA 10.0MP (College Station, TX). Table 1 lists the main relevant characteristics of the 51,413 subject study cohort. Of the patients studied, 41.79% were women and 79.6% were white. The mean age at critical care initiation was 61.7 yrs (SD 18.3). Thirty-day all-cause mortality was 14.2%. A total of 50.5% of patients were assigned a medical diagnosis-related group. A total of 15.4% of patients had an acute myocardial infarction. A total of 5.5% of the cohort underwent CABG and 13.5% of patients were septic. A total of 23.4% of patients were transfused red blood cells from 48 hrs before critical care initiation throughout the ICU stay.
RESULTS
Patient characteristics of the study cohort were stratified according to RDW levels at critical care initiation ( Table 2) . Factors that significantly differed between stratified groups included age, sex, race, patient type, Deyo-Charlson index, sepsis, acute myocardial infarction, CABG, congestive heart failure, transfusion, creatinine, blood urea nitrogen, white blood cell count, hematocrit, and number of organs with failure. An increasing gradient across RDW quintiles is observed in patients with creatinine Ͼ1.3 mg/dL, blood urea nitrogen Ͼ20 mg/dL, sepsis, Deyo-Charlson index Ն3, and number of organs with failure Ն2 ( Table  2 ). In the multivariable-adjusted analysis, age, patient type, Deyo-Charlson index, creatinine, hematocrit, white blood cells, blood urea nitrogen, mean corpuscular volume, CABG, sepsis, and transfusions are all significantly associated with 30day mortality (Table 3) .
RDW was a particularly strong predictor of all-cause mortality with a significant risk gradient across RDW quintiles ( Table 4 ). The risk of mortality 30 days after critical care initiation was 2.8-and 5.0-fold higher in patients with RDW values in the fourth and fifth highest quintiles, respectively, compared with those in the bottom quintile (RDW Յ13.3%). RDW in the cohort remains a significant predictor of risk of mortality after adjustment for age, sex, race, Deyo-Charlson index, patient type, CABG, myocardial in-farction, hematocrit, transfusion, creatinine, white blood count, mean corpuscular volume, blood urea nitrogen, sepsis, and creatinine. The adjusted risk of mortality 30 days after critical care initiation was 1.7-and 2.6-fold higher in patients with RDW values in the fourth and fifth highest quintiles, respectively, compared with those in the bottom quintile (Table  5 ). Similar significant robust associations pre-and postmultivariable adjustments are seen with death by days 90 and 365 postcritical care initiation as well as inhospital mortality (Tables 4 and 5 ).
In a subanalysis of patients with blood cultures drawn between 48 hrs before and 48 hrs subsequent to critical care initiation (n ϭ 18,525), RDW at critical care initiation was associated with a significant risk gradient for bloodstream infection across RDW quintiles. The risk of bloodstream infection was 1.8-and 2.0fold higher in patients with RDW values in the fourth and fifth highest quintiles, respectively, compared with those in the bottom quintile ( There is effect modification of the RD-W-mortality association on the basis of anemia defined as hematocrit Յ36% (30day mortality: interaction p ϭ .05; fully adjusted, data not shown). For 30-day mortality, the risk associated with RDW of 13.3% to 14.0% and RDW of 14.0% to 14.7% relative to RDW of Յ13.3% is not significant in the presence of anemia (hematocrit Յ36%). The mortality risk associated with RDW Ͼ14.7% is unchanged in the presence of hematocrit Յ36%. The number of patients with RDW Ͼ14.7% and hematocrit Յ36 was 12,839 with 22.1% inhospital mortality and 23.8% 30day mortality.
There is no significant effect modification of the RDW-mortality association on the basis of transfusion (30-day mortality: interaction p ϭ .17; fully adjusted, data not shown). Finally, there is no significant effect modification of the RDW-bloodstream infection association on the basis of anemia (interaction p ϭ .29) or transfusion (interaction p ϭ .24; all fully adjusted, data not shown). There is no effect modification of the RDW-mortality association on the basis of sepsis in the primary outcome (30-day mortality: interaction p ϭ .46; fully adjusted, data not shown).
To assess discrimination of RDW for 30-day mortality, we used receiver operating characteristic curve analysis and determined the AUC, also known as a concordance (C) statistic. Estimating the AUC shows that RDW has moderate discriminative power for 30-day mortality (AUC ϭ 0.67). RDW has marginal discriminative power for bloodstream infections (AUC ϭ 0.57).
DISCUSSION
The present study aimed to determine whether RDW was associated with allcause mortality after critical care initiation. The main findings of this study are the illustration of a graded independent relationship between RDW and all-cause mortality and also between RDW and bloodstream infection. RDW is a significant predictor of 30-, 90-, and 365-day mortality postcritical care initiation, inhospital mortality, and bloodstream infection. RDW remains a significant predictor of mortality and bloodstream infection after multivariable adjustments. The association between RDW and 30-day mortality is independent of transfusion status. The RDW-mortality association is independent of anemia (hematocrit Յ36%) when RDW is Ͼ14.7%. The RDW-bloodstream infection association is independent of transfusion status and anemia.
Sepsis significantly differed between RDW groups with a gradient of a higher percentage of septic patients in the higher RDW quintiles. (Table 2) . Patients with sepsis have a significantly increased odds of 30-day mortality after critical care (Table 3) . Despite these observations, there is no effect modification of the RD-W-mortality association on the basis of sepsis in the primary outcome. The interaction tests suggest that the association between RDW quintiles and 30-day mor-tality is the same in septic patients as in nonseptic patients.
In addition to adjusting for patients with myocardial infarction and congestive heart failure, we attempted to correct for known iatrogenic factors associated with an increase in RDW, including red blood cell transfusion and white blood count. Adding exogenous RBCs through repeated transfusions is known to skew the RDW (36) . The vast majority of patients under study (n ϭ 39,521) did not receive transfusions 48 hrs before critical care initiation or during the ICU stay. Because automated cell counters measure size by observing the change in resistance or light diffraction when an object enters the counting chamber, it is possible that particles other than single RBCs can make up the calculated RDW. Thus, fragmented schistocytes, coldagglutinated RBCs, and even very high numbers of white blood cells (Ͼ150,000/ L) may skew the automatically calculated RDW (19) . In our study cohort, we excluded patients with white blood cells Ͼ150,000/L but were unable to adjust for fragmented schistocytes or coldagglutinated RBCs, factors that may interfere with the RDW.
The mechanism for a RDW-mortality association is not known. Any process that results in the release of reticulocytes into the circulation will result in an increase in RDW. Elevations in RDW may have a negative impact on patient survival by reflecting the extent of inflammation. An association between increased RDW and changes in inflammatory biomarkers has been studied in general patient populations. Higher RDW is associated with increasing levels of inflammation markers in outpatients (9) . A graded direct association was found in outpatients between RDW and erythrocyte sedimentation rate/high-sensitivity C-reactive protein that was independent of age, sex, mean corpuscular volume, hemoglobin, and ferritin (9) .
Inflammation alters erythropoiesis by a variety of mechanisms, including direct myelosuppression of erythroid precursors, promotion of red cell apoptosis, reduction of erythropoietin production, reduced bioavailability of iron, and erythropoietin resistance in erythroid precursor cell lines (37, 38) . Inflammatory cytokines suppress erythrocyte maturation, accentuated with sepsis (39), allowing newer, larger reticulocytes to enter the circulation and skew RDW (13, 14) . Thus, inflammation likely leads to an Table 1 . Patient characteristics of the study population increased RDW from the release of immature RBCs into the peripheral circulation.
Inflammation and immune suppression is observed with surgical procedures, trauma, burn injury, or hemorrhage, which can predispose patients to nosoco-mial infections (40, 41) . Septic patients also have decreases in immune responsiveness predisposing to nosocomial infections (42) . T-regulatory cells appear to play a major role in the suppression of immune reactivity in injury (43, 44) and infection (45) . In such inflammatory or injury states, a decrease in the counterregulatory process from T-regulatory cells may result in dysfunctional responses to sepsis, inflammation, and injury. The observed correlations between RDW and inflammation (9 -12) may result in the increased risk of bloodstream infection and mortality observed in our study.
Oxidative stress may also be a contributing factor for the RDW-mortality association. High oxidative stress is present in sepsis through the generation of reactive oxygen species by activated leukocytes (46) . High oxidative stress contributing to elevated RDW by reducing RBC survival and increasing release of large premature red blood cells into the peripheral circulation (47) .
The RDW-mortality association in this study may also be related to the neurohumoral response to arterial underfilling. Such response involves arginine vasopressin, the renin-angiotensin-aldosterone system, and the sympathetic nervous system (48 -50) . Activation of the renin-angiotensin system triggers an acceleration of erythrocyte production resulting in an increased RDW through macrocytosis related to skipped cell divisions (51) (52) (53) . Such arterial underfilling states are common in cardiac failure and sepsis (54) , conditions that contribute to mortality and are common to our cohort.
The limitations of our study stem from its retrospective observational design with its inherent biases. Our finding that RDW at critical care initiation is a significant predictor of mortality does not include physiological data. In the administrative database used in this study, Acute Physiology and Chronic Health Evaluation scores are absent because both physiological data and Glasgow Coma Scale data are not available. Acute Physiology and Chronic Health Evaluation and other physiological-based scoring systems are strong predictors of mortality in the critically ill (55) . Adding a physiological score in the analysis may cause an alteration in the observed RDWmortality association. The Deyo-Charlson comorbidity index can be considered an alternative method of risk adjustment in the absence of physiological data when age and sex data are used (56) . However, despite multivariable adjustment of potential confounders, the absence of physiological data remains a limitation of our study.
Evaluating the sensitivity and specificity of the RDW with the use of receiver operating characteristic curve analysis, estimating the AUC shows that RDW has moderate discriminative power (AUC ϭ 0.67). In comparison, a prior study of a heterogeneous critical care population demonstrated the discriminative power of Acute Physiology and Chronic Health Evaluation II or Simplified Acute Physiology Score II to distinguish inhospital mortality; the AUC was 0.84 and 0.85, respectively (57) . In our study, as a result of data limitations, we are unable to directly compare the discrimination of RDW for 30-day mortality vs. Acute Physiology and Chronic Health Evaluation or Simplified Acute Physiology Score II.
Administrative coding data has been assessed for individual diseases (58 -62) and comorbidity profiles (48, 63) . There is controversy regarding the accuracy of ICD-9-CM coding for the identification of medical conditions (20) . The ICD-9-CM code 038.x is reported to have a high positive predictive value for the identification of true cases of sepsis (49) and a high sensitivity (50) , specificity (20) , and negative predictive value (20) . The Deyo-Charlson index algorithm used in this study (26) uses ICD-9 coding and is well studied and validated (64, 65) .
The present study has several strengths. All-cause mortality is an unbiased and clinically relevant outcome in long-term observational studies (54, 66) . Use of the Social Security Administration Death Master File allowed for complete 365-day follow-up for the cohort after hospital discharge. Our study has sufficient numbers of patients to ensure adequate reliability of our mortality estimates (n ϭ 51,413, inhospital mortality rate ϭ 12.8%). The basis of critical care initiation on CPT 99,291 codes in our administrative data set is validated (67) . Our use of previous records to define comorbidities increases their prevalence and results in a better risk adjustment (60, 68) . We include data for packed RBC transfusion before and during critical care, which is associated with respiratory failure and overall mortality in the critically ill (69) . Bloodstream infection and bloodstream infection rates are accepted end points in critical care studies (27) (28) (29) . Finally, RDW measurement time is uniform relative to the onset of critical care initiation.
CONCLUSIONS
In aggregate, these data demonstrate that RDW at critical care initiation is very strongly associated with the risk of death and the risk of bloodstream infection in critical illness and that this risk is independent of other risk factors. RDW is not a surrogate for a single disease process but is more reflective several processes found in critically ill patients. In the heterogenous population under study, increased RDW likely reflects the presence of proinflammatory cytokines and chemokines, oxidative stress, or arterial underfilling or a combination thereof. Inflammation and or oxidative stress may also contribute to the association of RDW and risk of bloodstream infection.
RDW is an inexpensive and common measurement found on the complete blood count. Although further research is needed to determine the mechanisms of the RDW-mortality association and the RDW-bloodstream infection association, this study provides support for future investigations to consider adding RDW to other established critical illness outcome markers to stratify critically ill patients at risk for infection and mortality. RDW, red cell distribution width. Note: Referent in each case is RDW Յ13.3%. Estimates adjusted for age, sex, race, Deyo-Charlson index, patient type (surgical vs. medical), coronary artery bypass grafting, myocardial infarction, congestive heart failure, hematocrit, transfusion (from 48 hrs before critical care initiation throughout the intensive care unit stay), white blood count, mean corpuscular volume, blood urea nitrogen, sepsis, and creatinine.
